Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1445]
News [2210]
Articles [39]
Editorials [5]
Conferences [150]
elearning [0]
Editor’s Choice for March 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for March 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
29 Mar 2018
Management of marker negative stage II testicular cancer
Dr Christian Kollmannsberger - University of British Columbia, Vancouver, Canada
Management of marker negative stage II testicular cancer ( Dr Christian Kollmannsberger - University of British Columbia, Vancouver, Canada )
16 Mar 2018
Durvalumab plus tremelimumab or durvalumab monotherapy in metastatic urothelial...
Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA
Durvalumab plus tremelimumab or durvalumab monotherapy in metastatic urothelial carcinoma ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018
Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma
Dr Jeffrey Graham - Tom Baker Cancer Centre, Calgary, Canada
Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma ( Dr Jeffrey Graham - Tom Baker Cancer Centre, Calgary, Canada )
9 Feb 2018
Genetic mutations: New therapeutic avenues in metastatic prostate cancer
Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Genetic mutations: New therapeutic avenues in metastatic prostate cancer ( Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
9 Feb 2018
Serum miRNA to predict post-chemotherapy viable disease in testicular non...
Dr Ricardo Leão - University of Toronto, Toronto, Canada
Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients ( Dr Ricardo Leão - University of Toronto, Toronto, Canada )
8 Feb 2018
Radium-223 for bone predominant metastatic castration resistant prostate cancer
Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA
Radium-223 for bone predominant metastatic castration resistant prostate cancer ( Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA )
8 Feb 2018
FALCON: Impact of 18F-fluciclovine PET/CT on management of biochemically...
Dr Eugene Teoh - University of Oxford, Oxford, UK
FALCON: Impact of 18F-fluciclovine PET/CT on management of biochemically recurrent prostate cancer ( Dr Eugene Teoh - University of Oxford, Oxford, UK )
8 Feb 2018
PROSPER RCC study of perioperative nivolumab for renal cell carcinoma - future...
Dr Lauren Harshman - Dana-Farber Cancer Institute, Boston, USA
PROSPER RCC study of perioperative nivolumab for renal cell carcinoma - future trial ( Dr Lauren Harshman - Dana-Farber Cancer Institute, Boston, USA )
8 Feb 2018
POUT: Phase III randomised trial of perioperative chemotherapy vs surveillance...
Dr Alison Birtle - Lancashire Teaching Hospitals NHS Foundation Trust...
POUT: Phase III randomised trial of perioperative chemotherapy vs surveillance in upper tract urothelial cancer ( Dr Alison Birtle - Lancashire Teaching Hospitals NHS Foundation Trust, Lancashire, UK )
8 Feb 2018
Latest in adjuvant therapy for renal cell carcinoma
Dr Naomi Haas - University of Pennsylvania, Philadelphia, USA
Latest in adjuvant therapy for renal cell carcinoma ( Dr Naomi Haas - University of Pennsylvania, Philadelphia, USA )
8 Feb 2018
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis...
Dr Ananya Choudhury - The Christie NHS Foundation Trust, Manchester, UK
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer ( Dr Ananya Choudhury - The Christie NHS Foundation Trust, Manchester, UK )
8 Feb 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation